JANE STREET GROUP, LLC - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 34 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$5,866,626
+149.5%
169,311
+108.3%
0.00%
Q1 2024$2,351,141
+40.6%
81,270
+11.4%
0.00%
Q4 2023$1,672,307
+160.4%
72,931
+89.4%
0.00%
Q3 2023$642,280
+6.6%
38,506
+76.6%
0.00%
Q2 2023$602,365
-53.4%
21,809
-61.2%
0.00%
-100.0%
Q1 2023$1,292,968
+112.0%
56,216
+0.6%
0.00%
Q4 2022$609,770
+600.9%
55,891
+443.2%
0.00%
Q3 2022$87,000
-71.0%
10,289
-72.9%
0.00%
Q2 2022$300,000
-58.7%
37,956
+23.6%
0.00%
Q1 2022$727,000
-81.5%
30,700
-73.2%
0.00%
-100.0%
Q4 2021$3,922,000
+282.6%
114,696
+98.3%
0.00%
Q3 2021$1,025,000
+251.0%
57,854
+299.7%
0.00%
Q4 2020$292,000
+12.7%
14,473
+9.1%
0.00%
Q3 2020$259,000
+197.7%
13,268
+2.5%
0.00%
Q2 2018$87,000
-62.5%
12,945
+18.1%
0.00%
-100.0%
Q3 2016$232,00010,9640.00%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 2,449,183$84,864,19121.18%
Cannon Global Investment Management, LLC 69,900$2,422,03511.28%
ADAR1 Capital Management, LLC 1,603,932$55,576,24410.49%
Checkpoint Capital L.P. 355,000$12,300,7507.42%
Fairmount Funds Management LLC 931,890$32,289,9893.65%
BVF INC/IL 3,319,290$115,013,3993.22%
RTW INVESTMENTS, LP 5,286,404$183,173,8992.84%
Kynam Capital Management, LP 800,000$27,720,0002.14%
683 Capital Management, LLC 604,449$20,944,1581.58%
Birchview Capital, LP 48,000$1,663,2001.54%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders